4.6 Article

Diffuse large B-cell lymphomas in adults with aberrant coexpression of CD10, BCL6, and MUM1 are enriched in IRF4 rearrangements

Related references

Note: Only part of the references are listed.
Article Pathology

B cell lymphoma with IRF4 rearrangement: A clinicopathological study of 13 cases

Luting Zhou et al.

Summary: Interferon regulatory factor 4 (IRF4) rearrangement is commonly detected in various lymphoproliferative malignancies, with large B cell lymphomas and low-grade B cell neoplasms being the most affected. Our study provides insights into the clinicopathological and genetic features of B cell lymphoma cases with IRF4 rearrangement, revealing both morphological and molecular heterogeneity.

PATHOLOGY INTERNATIONAL (2021)

Article Hematology

Distinct molecular profile of IRF4-rearranged large B-cell lymphoma

Joan Enric Ramis-Zaldivar et al.

BLOOD (2020)

Review Oncology

Toward a New Molecular Taxonomy of Diffuse Large B-cell Lymphoma

Daisuke Ennishi et al.

CANCER DISCOVERY (2020)

Article Oncology

Rare mature B-cell lymphomas in children and adolescents

Wilhelm Woessmann et al.

HEMATOLOGICAL ONCOLOGY (2019)

Article Medicine, General & Internal

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma

R. Schmitz et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Hematology

The genetic basis of diffuse large B-cell lymphoma

Laura Pasqualucci

CURRENT OPINION IN HEMATOLOGY (2013)

Article Genetics & Heredity

Analysis of the coding genome of diffuse large B-cell lymphoma

Laura Pasqualucci et al.

NATURE GENETICS (2011)

Article Multidisciplinary Sciences

Two levels of protection for the B cell genome during somatic hypermutation

Man Liu et al.

NATURE (2008)

Article Multidisciplinary Sciences

A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

G Wright et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Article Medicine, General & Internal

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

A Rosenwald et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)